ISLAMABAD: A training session was organised on pharmacovigilance by the Sonafi Aventis on the premises of the Drug Regulatory Authority of Pakistan here. The event was meant for the DRAP officers.
DRAP Chief Executive Officer Dr. Sheikh Akhter Hussain said the pharmacovigilance was an important component of medicine safety system and that his organisation was adamant at functioning of a central pharmacovigilance centre to coordinate with the provinces. "We have taken various steps to make the pharmacovigilance system in Pakistan more effective for Adverse Drug Reaction (ADRs) reporting, signal detection and data sharing," he said.
Trainer Anton Klishin, multi-country safety head from Sanofi-Aventis, Ukraine, emphasised the need for the introduction of risk management plan and signal detection and periodic reporting. The DRAP chief said the drug regulator had already initiated the process of capacity building of pharmacovigilance in Pakistan. "Few of the strategic steps taken in this context include associate membership of WHO Uppsala Monitoring Centre, Subscription of VigiFlow system, deployment of Integrated Regulatory Information management System (IRIMS).”
Crowd’s long wait due to persistent rain backed by heavy showers came to an end just for two deliveries with New...
Chief Justice Justice Faez Isa said amendments to the High Court Rules were necessary before appointment of judges
A division bench of the PHC comprising Justice SM Attique Shah and Justice Syed Arshad Ali heard the petition in which...
According to the Senate Secretariat, Gilani emphasized better coordination between the two Houses
